Previous 10 | Next 10 |
Gainers: [[AMAG]] +39.4%. [[DNOW]] +9.9%. [[DTIL]] +5.5% [[MNOV]] +5.0%. [[ODT]] +4.5%.Losers: [[LOGC]] -25.1%. [[SPI]] -15.6%. [[AMBO]] -5.9%. [[NG]] -5.9%. [[cc]] -4.3%. For further details see: AMAG, ODT, SPI and NG among after-hours movers
AMAG Pharmaceuticals (AMAG) jumps 41% after hours in apparent response to rumors that Apollo Global Management portfolio company Covis Pharma is about to acquire the company.The company sells two products: Makena (hydroxyprogesterone caproate injection) for reducing the risk of pret...
WALTHAM, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Scott Myers, Chief Executive Officer, and Brian Piekos, Chief Financial Officer, will participate in a fireside chat at the H.C. Wainwright 22 nd Annual Global Investment ...
AMAG Pharmaceuticals, Inc. (AMAG) Q2 2020 Earnings Conference Call August 06, 2020, 08:00 ET Company Participants Rushmie Nofsinger - Executive Director, Corporate Communications & Alliance Engagement Scott Myers - President, CEO & Director Anthony Casciano - EVP & CO...
Image source: The Motley Fool. AMAG Pharmaceuticals Inc (NASDAQ: AMAG) Q2 2020 Earnings Call Aug 6, 2020 , 8:00 a.m. ET Operator Continue reading
AMAG Pharmaceuticals (NASDAQ: AMAG ) : Q2 GAAP EPS of -$0.39 beats by $0.10 . More news on: AMAG Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Financial guidance reissued to include EBITDA-positive projection for second-half 2020 Strategic shift and momentum build through recent business development activities Brian Piekos promoted to Chief Financial Officer Conference call scheduled for 8:00 a.m. ET today WALTHAM...
WALTHAM, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its second quarter 2020 financial results will be released on Thursday, August 6, 2020 before the U.S. financial markets open. Management will host a conference call and webcast ...
Palatin Technologies (NYSEMKT: PTN ) jumps 10% premarket after terminating January 2017 license agreement with AMAG Pharmaceuticals (NASDAQ: AMAG ) , which granted latter exclusive rights to develop and commercialize Vyleesi (bremelanotide), a melanocortin rec...
Vyleesi® returned to Palatin Technologies Company focuses on optimizing marketed assets and development of its innovative pipeline WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced AMAG and Palatin Technolog...
News, Short Squeeze, Breakout and More Instantly...
AMAG Pharmaceuticals Inc. Company Name:
AMAG Stock Symbol:
NASDAQ Market:
AMAG Pharmaceuticals Inc. Website:
WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal to withdraw approval for Makena—also referred to as 17-OHP...
MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCap 600 MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&...
WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced today that it has formally requested a public hearing in response to the U.S. Food and Drug Administration’s (FDA) proposal to withdraw its approval of Makena ® , the only F...